Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial
Clinical Infectious Diseases · 08.02.2023 · 76 (3) · 433-442
DOI: 10.1093/cid/ciac787 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.09.2022. Verfasst von Rebekah W Moehring und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Infectious Diseases, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Sepsis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis guidelines recommend daily review to de-escalate or stop antibiotics in appropriate patients. This randomized, controlled trial evaluated an opt-out protocol to decrease unnecessary antibiotics in patients with suspected sepsis.
Methods
We evaluated non–intensive care adults on broad-spectrum antibiotics despite negative blood cultures at 10 US hospitals from September 2018 through May 2020. A 23-item safety check excluded patients with ongoing signs of systemic infection, concerning or inadequate microbiologic data, or high-risk conditions. Eligible patients were randomized to the opt-out protocol vs usual care. Primary outcome was post-enrollment antibacterial days of therapy (DOT). Clinicians caring for intervention patients were contacted to encourage antibiotic discontinuation using opt-out language. If continued, clinicians discussed the rationale for continuing antibiotics and de-escalation plans. To evaluate those with zero post-enrollment DOT, hurdle models provided 2 measures: odds ratio of antibiotic continuation and ratio of mean DOT among those who continued antibiotics.
Results
Among 9606 patients screened, 767 (8%) were enrolled. Intervention patients had 32% lower odds of antibiotic continuation (79% vs 84%; odds ratio, 0.68; 95% confidence interval [CI], .47–.98). DOT among those who continued antibiotics were similar (ratio of means, 1.06; 95% CI, .88–1.26). Fewer intervention patients were exposed to extended-spectrum antibiotics (36% vs 44%). Common reasons for continuing antibiotics were treatment of localized infection (76%) and belief that stopping antibiotics was unsafe (31%). Thirty-day safety events were similar.
Conclusions
An antibiotic opt-out protocol that targeted patients with suspected sepsis resulted in more antibiotic discontinuations, similar DOT when antibiotics were continued, and no evidence of harm. Clinical Trials Registration NCT03517007.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Infectious Diseases, Duke University, Durham, North Carolina, USA.
- Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.
- Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.
- Department of Pharmacy, Southeastern Regional Medical Center, Lumberton, North Carolina, USA.
- Department of Pharmacy, Piedmont Newnan Hospital, Newnan, Georgia, USA.
- Department of Pharmacy, Piedmont Atlanta Hospital, Atlanta, Georgia, USA.
Zitieren
APA
Moehring, R. W., Yarrington, M. E., Warren, B. G., Lokhnygina, Y., Atkinson, E., Bankston, A., Collucio, J., David, M. Z., Davis, A. E., Davis, J., Dionne, B., Dyer, A. P., Jones, T. M., Klompas, M., Kubiak, D. W., Marsalis, J., Omorogbe, J., Orajaka, P., Parish, A., …, & Centers for Disease Control and Prevention’s Prevention Epicenters Program (2023). Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial. Clinical Infectious Diseases, 76(3), 433-442. https://doi.org/10.1093/cid/ciac787
Vancouver
Moehring RW, Yarrington ME, Warren BG, Lokhnygina Y, Atkinson E, Bankston A, et al. Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial. Clinical Infectious Diseases. 2023;76(3):433-442. doi:10.1093/cid/ciac787
BibTeX
@article{Moehring2023,
author = {Moehring, Rebekah W and Yarrington, Michael E and Warren, Bobby G and Lokhnygina, Yuliya and Atkinson, Erica and Bankston, Allison and Collucio, Julia and David, Michael Z and Davis, Angelina E and Davis, Janice and Dionne, Brandon and Dyer, April P and Jones, Travis M and Klompas, Michael and Kubiak, David W and Marsalis, John and Omorogbe, Jacqueline and Orajaka, Patricia and Parish, Alice and Parker, Todd and Pearson, Jeffrey C and Pearson, Tonya and Sarubbi, Christina and Shaw, Christian and Spivey, Justin and Wolf, Robert and Wrenn, Rebekah H and Dodds Ashley, Elizabeth S and Anderson, Deverick J and Centers for Disease Control and Prevention’s Prevention Epicenters Program, Centers for Disease Control and Prevention’s Prevention Epicenters Program},
title = {Evaluation of an Opt-Out Protocol for Antibiotic De-Escalation in Patients With Suspected Sepsis: A Multicenter, Randomized, Controlled Trial},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {76},
number = {3},
pages = {433--442},
doi = {10.1093/cid/ciac787}
}
EUVIMED